Categories AlphaGraphs, Consumer, Earnings

Infographic: Highlights of Canopy Growth’s (CGC) Q3 2022 earnings

Cannabis producer Canopy Growth Corporation (NASDAQ: CGC) reported a narrower net loss for the third quarter of 2022, despite an 8% decrease in revenues.

Canopy Growth Q3 2022 earnings infographic

In the three months ended December 2021, net loss narrowed to C$108.9 million or C$0.28 per share from C$904.4 million or C$2.43 per share in the same period of the previous year. In the prior-year quarter, the bottom line was impacted by material non-cash asset impairment and restructuring charges.

Third-quarter revenues decreased 8% annually to C$140.9 million as strong growth in the consumer products segment was offset by a decline in Canadian cannabis sales.

“In the third quarter, we actioned to win where it matters – driving record performance in our CPG business from both BioSteel and Storz & Bickel while beginning to stabilize our Canadian business including maintaining the #1 position in premium flower. Our continued discipline and focus are expected to fortify Canopy’s competitive positioning in Canada as we ambitiously build our U.S. CPG, CBD, and THC strategies,” said David Klein, chief executive officer of Canopy Growth.


Read management/analysts’ comments on quarterly results


Canopy growth’s stock has been on a downward spiral for more than a year, losing about 81% during that period. CGC made modest gains at the Nasdaq stock exchange early Wednesday, after closing the previous session lower.

Prior Performance

  • Canopy Growth Q2 2022 earnings results

Most Popular

Infographic: Key metrics from Estee Lauder’s (EL) Q3 2024 earnings results

The Estee Lauder Companies Inc. (NYSE: EL) reported its third quarter 2024 earnings results today. Net sales were $3.94 billion, up 5% from the prior-year quarter. Organic sales increased 6%.

YUM Earnings: Key quarterly highlights from Yum! Brands’ Q1 2024 financial results

Yum! Brands, Inc. (NYSE: YUM) reported first quarter 2024 earnings results today. Total revenues decreased 3% year-over-year to $1.59 billion. Same-store sales declined 3%. Net income increased 5% to $314

Pfizer (PFE) Q1 2024 Earnings: Key financials and quarterly highlights

Pfizer Inc. (NYSE: PFE) reported first quarter 2024 earnings results today. Revenues decreased 20% year-over-year to $14.8 billion. Reported net income declined 44% to $3.1 billion, or $0.55 per share,

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top